PHOENIX BIOTECH ACQUISITION EQUITY WARRANTS EXP 1ST SEP 2026 Overview
Valuation check: PBAXW's P/E ratio is -0.27.
Get informed when a big investor buys or sells
+ Follow-0.27
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
PHOENIX BIOTECH ACQUISITION EQUITY WARRANTS EXP 1ST SEP 2026 (PBAXW) currently reports a P/E ratio of -0.27. Use the charts on this page to explore PHOENIX BIOTECH ACQUISITION EQUITY WARRANTS EXP 1ST SEP 2026's P/E ratio history and peer comparisons.
The P/E ratio is a valuation multiple that relates PHOENIX BIOTECH ACQUISITION EQUITY WARRANTS EXP 1ST SEP 2026's market price to a fundamental measure such as earnings, sales, or book value. At -0.27, PBAXW can look expensive or cheap only in context — versus its own history, growth rate, and sector peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current P/E ratio of -0.27, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for PHOENIX BIOTECH ACQUISITION EQUITY WARRANTS EXP 1ST SEP 2026, and consider following PBAXW for alerts when major investors trade the stock.
